A Phase 1 clinical trial to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of RG 7637
Latest Information Update: 01 Dec 2020
At a glance
- Drugs RG 7637 (Primary)
- Indications Developmental disabilities
- Focus Adverse reactions
- Sponsors Roche
- 01 Dec 2020 New trial record